These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35878838)

  • 1. The effect of adjunctive infliximab treatment on future cardiovascular disease risk in patients with bipolar disorder.
    Gill H; Rodrigues NB; Mansur RB; Marks CA; DiVincenzo JD; Ceban F; Rosenblat JD; Cao B; Lieberman JM; Ho R; McIntyre RS
    J Affect Disord; 2022 Nov; 316():273-279. PubMed ID: 35878838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression.
    Mansur RB; Delgado-Peraza F; Subramaniapillai M; Lee Y; Iacobucci M; Rodrigues N; Rosenblat JD; Brietzke E; Cosgrove VE; Kramer NE; Suppes T; Raison CL; Chawla S; Nogueras-Ortiz C; McIntyre RS; Kapogiannis D
    Cells; 2020 Apr; 9(4):. PubMed ID: 32268604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial.
    McIntyre RS; Subramaniapillai M; Lee Y; Pan Z; Carmona NE; Shekotikhina M; Rosenblat JD; Brietzke E; Soczynska JK; Cosgrove VE; Miller S; Fischer EG; Kramer NE; Dunlap K; Suppes T; Mansur RB
    JAMA Psychiatry; 2019 Aug; 76(8):783-790. PubMed ID: 31066887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depression.
    Lee Y; Mansur RB; Brietzke E; Carmona NE; Subramaniapillai M; Pan Z; Shekotikhina M; Rosenblat JD; Suppes T; Cosgrove VE; Kramer NE; McIntyre RS
    Brain Behav Immun; 2020 Aug; 88():631-639. PubMed ID: 32380271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral inflammatory biomarkers define biotypes of bipolar depression.
    Lee Y; Mansur RB; Brietzke E; Kapogiannis D; Delgado-Peraza F; Boutilier JJ; Chan TCY; Carmona NE; Rosenblat JD; Lee J; Maletic V; Vinberg M; Suppes T; Goldstein BI; Ravindran AV; Taylor VH; Chawla S; Nogueras-Ortiz C; Cosgrove VE; Kramer NE; Ho R; Raison CA; McIntyre RS
    Mol Psychiatry; 2021 Jul; 26(7):3395-3406. PubMed ID: 33658605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The risk of developing cardiovascular disease in bipolar disorder. Clinical and social factors].
    Mosolov SN; Fedorova EY
    Ter Arkh; 2021 Dec; 93(12):1556-1561. PubMed ID: 36286688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial.
    Savitz JB; Teague TK; Misaki M; Macaluso M; Wurfel BE; Meyer M; Drevets D; Yates W; Gleason O; Drevets WC; Preskorn SH
    Transl Psychiatry; 2018 Jan; 8(1):27. PubMed ID: 29362444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression.
    Mansur RB; Subramaniapillai M; Lee Y; Pan Z; Carmona NE; Shekotikhina M; Iacobucci M; Rodrigues N; Nasri F; Rashidian H; Rosenblat JD; Brietzke E; Cosgrove VE; Kramer NE; Suppes T; McIntyre RS
    Psychoneuroendocrinology; 2020 Oct; 120():104779. PubMed ID: 32603956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of infliximab on brain neurochemistry of adults with bipolar depression.
    Mansur RB; Subramaniapillai M; Lee Y; Pan Z; Carmona NE; Shekotikhina M; Iacobucci M; Rodrigues N; Nasri F; Rosenblat JD; Brietzke E; Cosgrove VE; Kramer NE; Suppes T; Newport J; Hajek T; McIntyre RS
    J Affect Disord; 2021 Feb; 281():61-66. PubMed ID: 33296798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the immune system in the treatment of bipolar disorder.
    Rosenblat JD
    Psychopharmacology (Berl); 2019 Oct; 236(10):2909-2921. PubMed ID: 30756134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The risk of developing cardiovascular disease in bipolar disorder. Biological factors and therapy].
    Mosolov SN; Fedorova EY
    Ter Arkh; 2022 May; 94(4):579-583. PubMed ID: 36286811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the gut microbiome associated with infliximab in patients with bipolar disorder.
    Bharwani A; Szamosi JC; Taylor VH; Lee Y; Bala A; Mansur R; Subramaniapillai M; Surette M; McIntyre RS
    Brain Behav; 2021 Aug; 11(8):e2259. PubMed ID: 34152099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive effects of creatine monohydrate adjunctive therapy in patients with bipolar depression: Results from a randomized, double-blind, placebo-controlled trial.
    Toniolo RA; Fernandes FBF; Silva M; Dias RDS; Lafer B
    J Affect Disord; 2017 Dec; 224():69-75. PubMed ID: 27890303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
    Raison CL; Rutherford RE; Woolwine BJ; Shuo C; Schettler P; Drake DF; Haroon E; Miller AH
    JAMA Psychiatry; 2013 Jan; 70(1):31-41. PubMed ID: 22945416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study.
    Ellegaard PK; Licht RW; Nielsen RE; Dean OM; Berk M; Poulsen HE; Mohebbi M; Nielsen CT
    J Affect Disord; 2019 Feb; 245():1043-1051. PubMed ID: 30699846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and psychiatric characteristics associated with oxidative stress markers among adolescents with bipolar disorder.
    Hatch J; Andreazza A; Olowoyeye O; Rezin GT; Moody A; Goldstein BI
    J Psychosom Res; 2015 Sep; 79(3):222-7. PubMed ID: 25934154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis.
    Rosenblat JD; Kakar R; Berk M; Kessing LV; Vinberg M; Baune BT; Mansur RB; Brietzke E; Goldstein BI; McIntyre RS
    Bipolar Disord; 2016 Mar; 18(2):89-101. PubMed ID: 26990051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Αnti-Inflammatory medication as adjunctive antidepressive treatment].
    Boufidou F; Nikolaou C
    Psychiatriki; 2016; 27(2):106-17. PubMed ID: 27467031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Improvement of Specific Symptoms Predicts Subsequent Recovery in Bipolar Depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Data.
    Mizushima J; Uchida H; Tada M; Suzuki T; Mimura M; Nio S
    J Clin Psychiatry; 2017 Feb; 78(2):e146-e151. PubMed ID: 28234437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.